22157.jpg
Global Cancer Gene Therapy Market 2023-2030: Gene Transfer and Immunotherapy Dominate Cancer Gene Therapy
October 03, 2023 05:43 ET | Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Gene Therapy Market by Therapy, End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast...
22157.jpg
Cancer Gene Therapy Global Market Report 2023: Increasing Research and Development Activities Bolster Growth
April 21, 2023 04:38 ET | Research and Markets
Dublin, April 21, 2023 (GLOBE NEWSWIRE) -- The "Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Therapy (Oncolytic Virotherapy,...
Cancer Gene Therapy Market
Cancer Gene Therapy Global Market Report 2022: Featuring Amgen, Novartis, Gilead Sciences, GlaxoSmithKline & More
January 19, 2023 06:33 ET | Research and Markets
Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Cancer Gene Therapy Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The cancer gene therapy market is...
22157.jpg
Gene Therapy in Oncology Market Report 2022: Growing Investment and Funding for Product Development Bolsters Sector
November 30, 2022 05:38 ET | Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene...
Global Cancer Gene Therapy Market
Cancer Gene Therapy Market Report 2022: High Growth in the Pharmaceutical Industry Driving Sector
November 14, 2022 08:21 ET | Research and Markets
Dublin, Nov. 14, 2022 (GLOBE NEWSWIRE) -- The "Cancer Gene Therapy Market Size, Share & Trends Analysis Report by Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), by...
22157.jpg
Global Cancer Gene Therapy Market Report 2022: Surge in Government Support & Biotechnological Funding Driving Growth
September 08, 2022 08:38 ET | Research and Markets
Dublin, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The "Cancer Gene Therapy Market By Therapy, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
22157.jpg
Asia Pacific Cancer Gene Therapy Market Report 2022: Featuring Key Players Novartis, GlaxoSmithKline, Amgen, Bristol Myers Squibb, Gilead Sciences,. Adaptimmune, Genelux & Sarepta Therapeutics,
August 04, 2022 04:53 ET | Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic...
22157.jpg
Global Cancer Gene Therapy Market Report to 2028 - Size, Share & Industry Trends Analysis Report
June 17, 2022 06:43 ET | Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and...
Cancer Gene Therapy
Cancer Gene Therapy Market size to exceed $4.3bn by 2024: Global Market Insights Inc.
September 13, 2016 07:00 ET | Global Market Insights
Ocean View, Delaware, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Cancer Gene Therapy Market size was USD 805.5 million in 2015, with 20.7% CAGR estimation from 2016 to 2024; as per a new research report...
Genelux Corporation Presents Abstracts at 2013 ASCO Annual Meeting for Clinical Trials of GL-ONC1, Its Oncolytic Virus Lead Product Candidate
May 30, 2013 07:30 ET | Genelux Corporation
SAN DIEGO, CA--(Marketwired - May 30, 2013) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapies and companion diagnostics, today...